Pages with the most revisions

Showing below up to 50 results in range #101 to #150.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Revolutionizing Nipah virus vaccinology: insights into subunit vaccine development strategies and immunological advances (1 revision)
  2. The latest advancements in Sosuga virus (SOSV) research (1 revision)
  3. Aerosol exposure to intermediate size Nipah virus particles induces neurological disease in African green monkeys (1 revision)
  4. Characterization of TheWe: Isolation and Phylogenetic Analysis of Nipah Virus from Pteropus vampyrus Bats (1 revision)
  5. Cat–wildlife interactions and zoonotic disease risk: a call for more and better community science data (1 revision)
  6. An Overview of Anthropogenic Actions as Drivers for Emerging and Re-Emerging Zoonotic Diseases (1 revision)
  7. Nipah Virus Encephalitis Reemergence, Bangladesh (1 revision)
  8. Nipah Virus-associated Encephalitis Outbreak, Siliguri, India (1 revision)
  9. Transmission of Nipah Virus — 14 Years of Investigations in Bangladesh (1 revision)
  10. Nipah Virus Outbreaks in Kerala: An Impending Doom? (1 revision)
  11. Beyond the Headlines: Why Henipaviruses Warrant Our Attention (1 revision)
  12. Nipah virus: a potential pandemic agent in the context of the current severe acute respiratory syndrome coronavirus 2 pandemic (1 revision)
  13. In silico prediction of interaction between Nipah virus attachment glycoprotein and host cell receptors Ephrin-B2 and Ephrin-B3 in domestic and peridomestic mammals (1 revision)
  14. An Immunoinformatic-Based In Silico Identification on the Creation of a Multiepitope-Based Vaccination Against the Nipah Virus (1 revision)
  15. Recombinant vesicular stomatitis virus–vectored vaccine induces long-lasting immunity against Nipah virus disease (1 revision)
  16. Nipah Virus Inhibitor Knowledgebase (NVIK): a combined evidence approach to prioritise small molecule inhibitors (1 revision)
  17. Detection of possible Nipah virus infection in Rousettus leschenaultii and Pipistrellus Pipistrellus bats in Maharashtra, India (1 revision)
  18. Severe zoonotic viruses carried by different species of bats and their regional distribution (1 revision)
  19. Nipah virus dynamics in bats and implications for spillover to humans (1 revision)
  20. Ribavirin Therapy for Nipah Virus Infection (1 revision)
  21. Encephalitis-predominant Nipah virus outbreaks in Kerala, India during 2024 (1 revision)
  22. Investigating Rare Risk Factors for Nipah Virus in Bangladesh: 2001–2012 (1 revision)
  23. Outbreak prone communicable diseases of public health importance in the northern districts of West Bengal – Current status & the way forward (1 revision)
  24. Nipah Virus Disease: Epidemiological, Clinical, Diagnostic and Legislative Aspects of This Unpredictable Emerging Zoonosis (1 revision)
  25. Piloting the promotion of bamboo skirt barriers to prevent Nipah virus transmission through date palm sap in Bangladesh (1 revision)
  26. Fruit bats as natural reservoir of highly pathogenic henipaviruses: balance between antiviral defense and viral tolerance (1 revision)
  27. Neurological pathophysiology of SARS-CoV-2 and pandemic potential RNA viruses: a comparative analysis (1 revision)
  28. Nipah Virus Bangladesh Infection Elicits Organ-Specific Innate and Inflammatory Responses in the Marmoset Model (1 revision)
  29. Development of a culture-independent whole-genome sequencing of Nipah virus using the MinION Oxford Nanopore platform (1 revision)
  30. The deadly drink: Nipah virus transmission through date palm sap, cultural practices and the evolution of behavioral interventions in Bangladesh over two decades (1 revision)
  31. Disease control tools to secure animal and public health in a densely populated world (1 revision)
  32. Nipah Virus in the Fruit Bat Pteropus vampyrus in Sumatera, Indonesia (1 revision)
  33. Infectious Causes of Acute Encephalitis Syndrome in India – Decadal Change and the Way Forward (1 revision)
  34. Nipah Virus Infection Outbreak with Nosocomial and Corpse-to-Human Transmission, Bangladesh (1 revision)
  35. Navigating Nipah virus: Insights, challenges, and recommendations (1 revision)
  36. Concern over Nipah virus cases amidst the COVID‐19 pandemic in India (1 revision)
  37. Scoping future outbreaks: a scoping review on the outbreak prediction of the WHO Blueprint list of priority diseases (1 revision)
  38. Nipah and Hendra Viruses: Deadly Zoonotic Paramyxoviruses with the Potential to Cause the Next Pandemic (1 revision)
  39. Full genome sequence of Nipah virus from an outbreak in India (1 revision)
  40. A comparative genomic approach to decipher the mutations associated with Nipah viral human isolates from southeast Asia (1 revision)
  41. The Genetic Diversity of Nipah Virus Across Spatial Scales (1 revision)
  42. Pathogenic Differences between Nipah Virus Bangladesh and Malaysia Strains in Primates: Implications for Antibody Therapy (1 revision)
  43. Bats Without Borders: Long-Distance Movements and Implications for Disease Risk Management (1 revision)
  44. Assessing the risk of Nipah virus establishment in Australian flying-foxes (1 revision)
  45. Trends in Bacterial Pathogens of Bats: Global Distribution and Knowledge Gaps (1 revision)
  46. Flying-Fox Species Density - A Spatial Risk Factor for Hendra Virus Infection in Horses in Eastern Australia (1 revision)
  47. Henipavirus Encephalitis: Recent Developments and Advances (1 revision)
  48. Outbreak of Henipavirus Infection, Philippines, 2014 (1 revision)
  49. Structural and functional analysis of the Nipah virus polymerase complex (1 revision)
  50. Lessons from the pandemic: Responding to emerging zoonotic viral diseases—a Keystone Symposia report (1 revision)

View ( | ) (20 | 50 | 100 | 250 | 500)